Skip to main content
Top
Published in: Journal of General Internal Medicine 11/2016

01-11-2016 | Clinical Practice: Clinical Images

Drug-induced bullous pemphigoid

Authors: Satoko M. Kanahara, MD, Anoop Agrawal, MD

Published in: Journal of General Internal Medicine | Issue 11/2016

Login to get access

Excerpt

A previously healthy 28-year-old man presented with a rash for 1 month. He had taken griseofulvin for a week prior to rash onset. He had visited two ERs and was given minocycline and valacyclovir, followed by acyclovir, hydroxyzine and low-dose oral steroids, with no improvement. On presentation to our clinic, he had vesicular lesions and large bullae over his forearms and thighs (Figs. 1 and 2). No mucosal lesions were present. Lab test results demonstrated WBC 10.2 K/cmm with 8.4% eosinophils. Perilesional skin biopsy showed spongiotic dermatitis with eosinophils, with direct immunofluorescence positive for subepidermal IgG and C3 depositions consistent with bullous pemphigoid. He was treated with oral prednisone and clobetasol ointment, with improvement.1
Literature
1.
go back to reference Pacheco D, Lopes L, Soares-Almeida L, Marques MS, Filipe P. “Half-half” blisters in bullous pemphigoid successfully treated with adjuvant high-dose intravenous immunoglobulin. Acta Dermatovenerol Alp Panonica Adriat. 2012;21:59–61. Pacheco D, Lopes L, Soares-Almeida L, Marques MS, Filipe P. “Half-half” blisters in bullous pemphigoid successfully treated with adjuvant high-dose intravenous immunoglobulin. Acta Dermatovenerol Alp Panonica Adriat. 2012;21:59–61.
2.
go back to reference Ahronowitz I, Fox L. Severe drug-induced dermatoses. Semin Cutan Med Surg. 2014;33:49–58.PubMed Ahronowitz I, Fox L. Severe drug-induced dermatoses. Semin Cutan Med Surg. 2014;33:49–58.PubMed
3.
go back to reference Stavropoulos PG, Soura E, Antoniou C. Drug-induced pemphigoid: a review of the literature. J Eur Acad Dermatol Venereol. 2014;28:1133–40.CrossRefPubMed Stavropoulos PG, Soura E, Antoniou C. Drug-induced pemphigoid: a review of the literature. J Eur Acad Dermatol Venereol. 2014;28:1133–40.CrossRefPubMed
4.
go back to reference Lee JJ, Downham TF 2nd. Furosemide-induced bullous pemphigoid: case report and review of literature. J Drugs Dermatol. 2006;5:562–4.PubMed Lee JJ, Downham TF 2nd. Furosemide-induced bullous pemphigoid: case report and review of literature. J Drugs Dermatol. 2006;5:562–4.PubMed
5.
go back to reference Walsh SR, Hogg D, Mydlarski PR. Bullous pemphigoid: from bench to bedside. Drugs. 2005;65:905–26.CrossRefPubMed Walsh SR, Hogg D, Mydlarski PR. Bullous pemphigoid: from bench to bedside. Drugs. 2005;65:905–26.CrossRefPubMed
Metadata
Title
Drug-induced bullous pemphigoid
Authors
Satoko M. Kanahara, MD
Anoop Agrawal, MD
Publication date
01-11-2016
Publisher
Springer US
Published in
Journal of General Internal Medicine / Issue 11/2016
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-016-3679-1

Other articles of this Issue 11/2016

Journal of General Internal Medicine 11/2016 Go to the issue

Letter to the Editor

Vitamin D: Ten Beliefs

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.